I am a
Home I AM A Search Login

Papers of the Week


2020 03


Lancet Neurol


19


3

β-adrenoreceptors and the risk of Parkinson’s disease.

Authors

Hopfner F, Höglinger GU, Kuhlenbäumer G, Pottegård A, Wod M, Christensen K, Tanner CM, Deuschl G
Lancet Neurol. 2020 03; 19(3):247-254.
PMID: 31999942.

Abstract

β-adrenoceptors are widely expressed in different human organs, mediate important body functions and are targeted by medications for various diseases (such as coronary heart disease and heart attack) and many β-adrenoceptor acting drugs are listed on the WHO Model List of Essential Medicines. β-adrenoceptor antagonists are used by billions of patients with neurological disorders, primarily for the treatment of migraine and action tremor (mainly essential tremor), worldwide.